$0.749
-0.089 (-11.91%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Coherus Oncology Inc (CHRS) Moving Averages Convergence Divergence (MACD) indicator is -0.09, suggesting CHRS is Strong sell.
Coherus Oncology Inc (CHRS) 20-Day simple moving average is 0.97, while Coherus Oncology Inc (CHRS) share price is $—, making it Sell.
Coherus Oncology Inc (CHRS) 60-Day simple moving average is 1.18, while Coherus Oncology Inc (CHRS) share price is $—, making it Sell.
Technical Analysis for CHRS
AI Technical CHRSAs of 2026-11-03, the technical board for Coherus Oncology Inc (CHRS) reads strong sell: 2 indicators are flashing buy, 9 are indicating sell, and 2 are neutral. Price at $0.75 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 34.536, MACD stands at -0.0943 (Sell), Stochastic %K stands at 14.193 (Buy), Stochastic %D stands at 11.527 and CCI stands at -154.188 (Buy).
CHRS trades below the 60-day SMA (1.18) and below the 200-day SMA (1.51). Immediate resistance sits at Classic R1 1.14, then R2 1.38. Support sits at Classic S1 0.71, then S2 0.50.
Coherus Oncology Inc (CHRS) Support & Resistance Level
Coherus Oncology Inc (CHRS) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 34.536 |
| STOCHk_14_3_3 | 14.193 |
| STOCHd_14_3_3 | 11.527 |
| CCI_20 | -154.188 |
| AO_5_34 | -0.237 |
| MOM_10 | -0.301 |
| MACD_12_26_9 | -0.094 |
Coherus Oncology Inc (CHRS) Relative Strength Index (RSI_14) is 34.536, creating a Neutral signal.
Coherus Oncology Inc (CHRS) Stochastic %K is 14.193, creating a Buy signal.
Coherus Oncology Inc (CHRS) Stochastic %D is 11.527, creating a Buy signal.
Coherus Oncology Inc (CHRS) CCI_20 is -154.188, creating a Buy signal.
Coherus Oncology Inc (CHRS) Awesome Oscillator (AO) is -0.237, creating a Sell signal.
Coherus Oncology Inc (CHRS) Momentum (MOM) is -0.301, creating a Sell signal.
Coherus Oncology Inc (CHRS) Moving Average Convergence Divergence (MACD) is -0.094, creating a Sell signal.
Coherus Oncology Inc (CHRS) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.797 | Sell |
| MA_10 | 0.913 | Sell |
| MA_20 | 0.972 | Sell |
| MA_60 | 1.176 | Sell |
| MA_200 | 1.514 | Sell |
| MA_250 | 1.484 | Sell |
Coherus Oncology Inc (CHRS) 5-Day simple moving average is 0.797, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Coherus Oncology Inc (CHRS) 10-Day simple moving average is 0.913, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Coherus Oncology Inc (CHRS) 20-Day simple moving average is 0.972, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Coherus Oncology Inc (CHRS) 60-Day simple moving average is 1.176, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Coherus Oncology Inc (CHRS) 200-Day simple moving average is 1.514, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Coherus Oncology Inc (CHRS) 250-Day simple moving average is 1.484, while Coherus Oncology Inc (CHRS) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.